NOVABAY PHARMACEUTICALS |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.084 USD | +9.09% |
|
+4.13% | -57.94% |
| Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
| Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar NovaBay Pharmaceuticals
585ad8c30.iHLyj1O970cKoDBUhSB_BRiLq85GA4gVdGBS8j4NEx0.4z6Q6WeLgzBj0QVn2hcYKFy4nfx0O_FMOgUqq0tOIGX6LcfnB-uLfmT3dQ~44c9ad8445d376a51b6753329765102d
Upcoming events on NovaBay Pharmaceuticals
No events available
Past events on NovaBay Pharmaceuticals
| 2022-11-15 | Reverse Split: 1 of 35 |
| 2022-08-11 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-11 04:05 pm | Interim 2022 Earnings Release |
| 2022-05-12 04:30 pm | Q1 2022 Earnings Call |
| 2022-05-12 04:05 pm | Q1 2022 Earnings Release |
| 2022-03-29 04:30 pm | FY 2021 Earnings Call |
| 2022-03-29 04:05 pm | FY 2021 Earnings Release |
| 2022-01-31 02:00 pm | Extraordinary Shareholders Meeting - Third Call |
| 2022-01-13 | Extraordinary Shareholders Meeting - Second Call |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2021-12-16 | Extraordinary Shareholders Meeting - First Call |
| 2021-11-11 04:30 pm | Q3 2021 Earnings Call |
| 2021-11-11 04:05 pm | Q3 2021 Earnings Release |
| 2021-09-29 04:30 pm | Acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc Call |
| 2021-09-12 | H.C. Wainwright Global Investment Conference |
| 2021-08-12 04:30 pm | Interim 2021 Earnings Call |
| 2021-08-12 04:05 pm | Interim 2021 Earnings Release |
| 2021-07-28 | A.G.P.’s Virtual MedTech Summer Conference |
| 2021-07-14 04:30 pm | Ladenburg Thalmann Healthcare Conference |
| 2021-05-06 04:30 pm | Q1 2021 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,60 6,97 -5.32% | 9,93 10,5 -5.39% | 8,42 9,14 -7.82% | 14,4 14,2 1.22% | 14,7 14,4 2.26% | 14,8 |
|
EBITDA Million USD | Released Forecast Spread | -9,34 -8,30 -12.47% | -6,38 -5,70 -11.84% | -8,74 -6,80 -28.57% | -7,20 -4,50 -59.93% | -7,39 -5,50 -34.42% | -2,60 |
|
EBIT Million USD | Released Forecast Spread | -9,40 -8,99 -4.56% | -6,43 -6,48 0.76% | -8,86 -8,59 -3.17% | -7,68 -5,76 -33.33% | -7,60 -6,20 -22.52% | -3,35 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,65 -8,79 -9.81% | -11,0 -11,1 0.86% | -5,82 -8,59 32.16% | -10,6 -5,97 -77.84% | -9,64 -9,50 -1.47% | -3,35 |
|
Net income Million USD | Released Forecast Spread | -10,5 -8,80 -19.24% | -11,0 -11,1 0.82% | -6,56 -8,59 23.6% | -16,3 -5,97 -172.67% | -16,7 -9,50 -75.76% | -3,35 |
|
EPS USD | Released Forecast Spread | -16,8 -14,9 -12.94% | -10,9 -11,2 3.12% | -5,25 -6,30 16.67% | -10,1 -4,05 -149.38% | -3,96 -2,31 -71.43% | -0,27 |
| Announcement Date | 26/03/20 | 25/03/21 | 29/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,64 3,35 -21.05% | 2,63 3,26 -19.36% | 3,05 3,51 -13.25% | 3,83 3,74 2.3% | 3,64 4,73 -22.98% | 3,12 3,20 -2.38% | 4,61 3,68 25.44% | 3,27 3,55 -7.9% | 3,73 3,40 9.62% | 3,28 | 3,58 | 3,71 | 4,24 | 4,39 |
|
EBITDA Million USD | Released Forecast Spread | -3,11 -1,90 -63.58% | -2,35 -3,10 24.13% | -2,03 -2,30 11.65% | -0,34 -1,30 74% | -2,57 0,00 - | -1,68 -1,80 6.5% | -1,30 -1,60 18.5% | -1,07 -1,40 23.93% | -3,34 -1,60 -108.81% | -1,10 | -0,90 | -0,50 | -0,20 | 0,10 |
|
EBIT Million USD | Released Forecast Spread | -3,20 -2,91 -9.98% | -2,38 -2,90 17.72% | -2,15 -2,53 14.94% | -0,46 -1,95 76.56% | -2,69 -0,76 -253.82% | -1,73 -2,10 17.43% | -1,36 -2,09 35.17% | -1,12 -1,65 32.16% | -3,39 -2,00 -69.55% | -1,32 | -1,08 | -0,71 | -0,24 | -0,36 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,16 -2,91 94.53% | -0,11 -2,15 94.83% | -2,16 -2,38 9.45% | -0,14 -1,80 92.44% | -8,21 -0,76 -979.74% | -1,74 -2,10 17.19% | -2,04 -2,09 2.58% | -1,76 -1,65 -6.81% | -4,11 -2,00 -105.4% | -1,32 | -1,08 | -0,71 | -0,24 | -0,36 |
|
Net income Million USD | Released Forecast Spread | -0,89 -2,91 69.23% | -0,11 -2,15 94.83% | -2,16 -2,38 9.45% | -5,79 -1,80 -221.83% | -8,21 -0,76 -979.74% | -1,74 -2,10 17.19% | -4,03 -2,09 -92.92% | -1,76 -1,65 -6.81% | -9,17 -2,00 -358.45% | -1,32 | -1,08 | -0,71 | -0,24 | -0,36 |
|
EPS USD | Released Forecast Spread | -1,05 -1,75 40% | 0,00 -1,05 - | -1,40 -1,23 -14.29% | -3,50 -1,05 -233.33% | -4,33 -0,37 -1086.3% | -0,85 -0,91 6.59% | -1,27 -0,56 -128.83% | -0,37 -0,41 8.64% | -1,33 -0,30 -343.33% | -0,15 | -0,09 | -0,06 | -0,01 | -0,03 |
| Announcement Date | 29/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | - | - | - | - | - |
Past sector events for NovaBay Pharmaceuticals
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NBY Stock
- Calendar NovaBay Pharmaceuticals
